Sign In
Buy HOLX
$76.01
+0 (+0%)
At Close: Jun 03, 2026
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
10:01am, Wednesday, 20'th Aug 2025
HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?
10:01am, Friday, 15'th Aug 2025
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
09:26am, Wednesday, 13'th Aug 2025
HOLX targets a mid-single-digit organic growth rebound in 2026, powered by Breast Health recovery and new product innovation.
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
09:46am, Friday, 08'th Aug 2025
HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?
08:41am, Wednesday, 06'th Aug 2025
HOLX rises post earnings beat, fueled by Diagnostics strength and Surgical growth. However, macro headwinds persist.
Why Hologic (HOLX) is a Top Value Stock for the Long-Term
10:41am, Monday, 04'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Interpreting Hologic (HOLX) International Revenue Trends
10:16am, Monday, 04'th Aug 2025
Evaluate Hologic's (HOLX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
10:02am, Monday, 04'th Aug 2025
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down
09:00am, Thursday, 31'st Jul 2025
HOLX posts better-than-expected Q3 results, but margin contraction and regional headwinds pressure investor sentiment.
Hologic (HOLX) Q3 Revenue Beats 1%
05:03am, Thursday, 31'st Jul 2025
Hologic (HOLX) Q3 Revenue Beats 1%
Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript
07:12pm, Wednesday, 30'th Jul 2025
Hologic, Inc. (NASDAQ:HOLX ) Q3 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Essex D. Mitchell - Chief Operating Officer Karleen M.
Compared to Estimates, Hologic (HOLX) Q3 Earnings: A Look at Key Metrics
06:31pm, Wednesday, 30'th Jul 2025
The headline numbers for Hologic (HOLX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
06:11pm, Wednesday, 30'th Jul 2025
Hologic (HOLX) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.06 per share a year ago.
Hologic raises annual profit forecast on diagnostic and surgical demand
06:06pm, Wednesday, 30'th Jul 2025
Medical equipment maker Hologic on Wednesday raised its annual profit forecast, anticipating strong demand for its molecular diagnostic devices and surgical products.
Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver?
09:06am, Tuesday, 29'th Jul 2025
HOLX eyes a Breast Health rebound in Q4, backed by leadership changes, new strategy and Endomag momentum.
